Maryleen Lovell-Petronilia, MSc, is a Medical Biologist specialized in Molecular Pathology, with over 14 years of experience in clinical research and healthcare innovation. In 2022, following a 10-year tenure at a prominent University Medical Center, during which she introduced Risk Management into routine clinical Pathology, Maryleen assumed the role of Manager of Quality Assurance and Compliance at EmVenio Clinical Research (f.k.a. PCM Trials).
In this capacity, she is dedicated to improving and ensuring quality oversight and compliance with regulatory requirements and country-specific regulations.
Maryleen is committed to advancing the global adoption of patient-centricity while fostering collaboration among stakeholders to promote and maintain high standards for decentralized elements of clinical trials.